SEC Tracker
Get the app
XAIR · XBRL financial data

Beyond Air financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (XAIR's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Revenue from contracts with customers239391470*6837981,0721,152*1,7601,8182,1941,907*1,768
Cost of revenue432748983*1,0161,8821,2871,184*1,6042,1161,8941,813*1,543
Gross profit(193)(356)(513)*(332)(1,084)(215)(32)*156(298)30094*225
Research and development7,1306,8385,699*6,0094,5853,0053,258*3,0862,4502,4292,276*1,959
Selling, general and administrative10,2119,7686,422*7,2397,1637,7323,884*4,6874,9134,4674,988*4,878
General and administrative10,2119,7686,422*—————————
Total operating expenses17,34216,60612,122*13,24711,74810,7377,142*7,7737,3636,8967,264*6,837
Operating income (loss)(17,535)(16,963)(12,634)*(13,580)(12,833)(10,952)(7,174)*(7,617)(7,661)(6,596)(7,170)*(6,612)
Interest expense914919921*964927549580*5486391,0881,240*1,492
Other income (expense)0*35(127)*(2)49(37)(2)*9448(162)6*—
Net income (loss)(16,220)(16,220)(13,707)*(12,201)(13,358)(13,032)(8,034)*(7,691)(7,940)(7,336)(10,282)*(7,935)
Earnings per share, basic USD per share(0.51)(0.50)(0.37)*(0.27)(0.28)(0.15)—(1.53)(1.25)(0.85)—(11.00)
Earnings per share, diluted USD per share(0.51)(0.50)(0.37)*(0.27)(0.28)(0.15)—(1.53)(1.25)(0.85)—(11.00)
Weighted average shares, basic thousands of shares31,80032,46237,017*45,90147,11988,075—5,0156,3578,617—721
Weighted average shares, diluted thousands of shares31,80032,46237,017*45,90147,11988,075—5,0156,3578,617—721
  • † Share count changed about 1/18 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/15 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (XAIR's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Cash and cash equivalents13,1797,97111,3784,16128,4474,6014,6654,9769,6996,6436,7405,509
Marketable securities25,46323,29223,09017,213—6,3492,2521,4879965,0184,9014,303
Marketable securities, non-current00000———————
Accounts receivable2052943194755566397108048921,1511,0861,140
Inventory1,5741,5332,1272,3912,5272,3792,4172,4332,2291,7611,4061,292
Prepaid and other current assets1,4816,1186,7926,4056,2755,1445,7435,1264,6074,8045,0125,200
Total current assets47,13439,43943,93630,87438,03619,34416,01814,98918,58625,56424,76722,849
Property and equipment, net6,8248,5519,36412,11711,64811,65211,01310,1889,3928,5028,2497,916
Right-of-use asset2,2942,2292,1212,0211,8971,7751,7061,6541,5611,4641,1931,066
Total assets58,00551,91156,96146,50053,01034,14430,06228,11430,96536,77435,38532,891
Accounts payable3,2923,2201,9483,1141,4902,3571,9501,2421,9152,2022,4172,455
Accrued liabilities8,4967,882——————————
Total current liabilities12,45411,64111,56711,7536,5995,4305,0004,6264,3834,9896,5116,907
Lease liability, non-current2,0872,0121,8981,7901,6901,5671,4861,4191,3001,2311,023977
Total liabilities29,17328,44029,77528,80123,71615,76315,72117,70617,87028,48829,17530,052
Accumulated deficit(209,770)(225,990)(239,697)(251,898)(265,255)(278,288)(286,322)(294,013)(301,953)(309,289)(319,571)(327,506)
Total stockholders' equity25,74620,81425,04816,13028,12717,64413,5839,92712,7338,1116,1261,997
Total liabilities and equity58,00551,91156,96146,50053,01034,14430,06228,11430,96536,77435,38532,891
Common shares outstanding (cover page) thousands of shares31,97236,03945,90146,52172,18888,27992,7955,2268,00910,52914,411958
  • † Share count changed about 1/18 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/15 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (XAIR's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025†Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Net income (loss)(16,220)(16,220)(13,707)*(12,201)(13,358)(13,032)(8,034)*(7,691)(7,940)(7,336)(10,282)*(7,935)
Stock-based compensation6,4606,4352,327*3,3793,1292,479158*1,5771,7751,503427*1,036
Net cash from operating activities(14,319)*(13,817)*(10,725)*(10,180)(13,348)*(7,733)*(6,957)*(4,526)(4,453)*(4,219)*(4,946)*(4,946)
Purchases of property and equipment1,682*1,337*1,931*2,6731,175*537*1,498*198246*34*547*208
Net cash from investing activities(1,768)*853*(1,667)*3,11416,147*(6,937)*2,581*576240*(4,043)*(447)*461
Proceeds from issuing common stock687*5,472*———0*0*———3,800*—
Proceeds from long-term debt———1000*———————
Net cash from financing activities469*5,238*15,893*(264)21,624*(9,214)*4,500*4,0668,918*11,205*4,901*3,058
Net change in cash(15,677)*(7,689)*3,405*(7,218)24,287*(23,845)*64*2434,723*2,968*(468)*(1,448)
  • † Share count changed about 1/18 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/15 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Beyond Air5,5091,768(4,946)957,6312.0 quarters 10-QJun 30, 2026
RetinalGenix Technologies27not reported(137)*18.8M0.2 quarters 10-QJun 30, 2026
Harvard Apparatus Regenerative Technology351414(569)*17.6M0.6 quarters 10-QJun 30, 2026
Nexalin Technology1,00512(1,802)*22.0M0.6 quarters 10-QJun 30, 2026
Iridex4,68012,566174*17.6M— 10-QJul 4, 2026
Biotricity4674,27750719.9M— 10-QJun 30, 2026
Encision721,528(127)*16.9M0.6 quarters 10-QSep 30, 2025
VASO38,291not reported17,444*176.0M— 10-QJun 30, 2026
Envoy Medical19,67951(5,456)*77.2M3.6 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.